Home Cart Sign in  
Chemical Structure| 1139889-93-2 Chemical Structure| 1139889-93-2

Structure of Golgicide A
CAS No.: 1139889-93-2

Chemical Structure| 1139889-93-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Golgicide A is a potent, highly specific, reversible inhibitor of the cis-Golgi ArfGEF GBF1, which decreases Arf1 activation.

Synonyms: GCA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Golgicide A

CAS No. :1139889-93-2
Formula : C17H14F2N2
M.W : 284.30
SMILES Code : FC1=CC2=C(NC(C3=CC=CN=C3)[C@@]4([H])[C@]2([H])C=CC4)C(F)=C1
Synonyms :
GCA
MDL No. :MFCD27937048
InChI Key :NJZHEQOUHLZCOX-FTLRAWMYSA-N
Pubchem ID :25113626

Safety of Golgicide A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • ATPase

In Vitro:

Cell Line
Concentration Treated Time Description References
293sw cells 3.5 μM 8 h GCA reduced basal secreted Aβ levels PMC9406471
A549 cells 20 μM 5 h Enhanced HAdV-C5-dE1_GFP infection PMC4249087
Primary astrocytes 3.5 μM 8 h GCA reduced basal secreted Aβ levels PMC9406471
WI38 fibroblasts 20 μM 5 h Not used PMC4249087
M950822 and M980928 melanoma cells 20 μM 5 h Enhanced HAdV-C5-dE1_GFP infection PMC4249087
HeLa-ATCC cells 20 μM 5 h Enhanced HAdV-C2-dE3B_GFP infection PMC4249087
SF188 cells 10 μM 14 h PTEN knockdown significantly increased cell sensitivity to secretion inhibitors BFA and GCA, leading to increased cell death. PMC6008332
Vero cells 10 μM 1 h GCA treatment resulted in complete dispersal of the Golgi and TGN, similar to the effects of BFA. PMC3500152
BEAS-2B bronchial epithelial cells 4 µM 24 h Artificial induction of Golgi fragmentation, reducing bacterial adherence but increasing bacterial replication PMC10436572
BEAS-2B bronchial epithelial cells 4 µM 4 h Artificial induction of Golgi fragmentation, reducing bacterial adherence but increasing bacterial replication PMC10436572
HEL cells 10 µM 48 h Golgicide A blocked STING exocytosis from HSV-1-infected cells, indicating that STING trafficking through the Golgi is required. PMC11005388
BHK-21 cells 27 μM 24 h Evaluate the effect of Golgicide A on DENV NS1 secretion, results showed NS1 secretion was reduced more than 70% in vertebrate cells PMC6364000
Aag2 cells 27 μM 24 h Evaluate the effect of Golgicide A on DENV NS1 secretion, results showed no effect on NS1 secretion in mosquito cells PMC6364000
C6/36 cells 27 μM 24 h Evaluate the effect of Golgicide A on DENV NS1 secretion, results showed no effect on NS1 secretion in mosquito cells PMC6364000
MA104 cells 10 μM 12 h Evaluate the effect of GCA on rotavirus replication, showing a significant reduction in viral yield PMC6744240

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Subcutaneous xenograft model Subcutaneous injection 20 mg/kg and 50 mg/kg Once a week for 4 weeks Evaluate the inhibitory effect of GCA on tumor growth PMC11887147

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.59mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

References

 

Historical Records

Categories